| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/06/2005 | WO2005001486A1 Modulating the interaction between hgf beta chain and c-met |
| 01/06/2005 | WO2005001485A2 Pem-3-like compositions and related methods thereof |
| 01/06/2005 | WO2005001484A1 Method of judging the onset of periodontitis |
| 01/06/2005 | WO2005001483A2 Methods for diagnisis and differential diagnosis of dementia disorders |
| 01/06/2005 | WO2005001482A1 Modulation of osteoblast activity by fhl2 |
| 01/06/2005 | WO2005001481A1 Detection of protease-resistant prion protein following a spontaneous transformation reaction |
| 01/06/2005 | WO2005001480A1 Method of isolating a protein |
| 01/06/2005 | WO2005001479A1 Capacitative biosensor element and method for detecting hybridization events |
| 01/06/2005 | WO2005001478A1 Methods for identifying agents, which regulate cytokines |
| 01/06/2005 | WO2005001477A2 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same |
| 01/06/2005 | WO2005001476A1 Method of preparing array |
| 01/06/2005 | WO2005001475A2 Apparatus and method for detecting microscopic living organisms using bacteriophage |
| 01/06/2005 | WO2005001474A1 System and method for coding information on a biosensor test strip |
| 01/06/2005 | WO2005001473A1 Diagnosis of oil and oil bearing equipment |
| 01/06/2005 | WO2005001472A1 Method of screening substance with anticancerous activity and apparatus therefor |
| 01/06/2005 | WO2005001471A1 Accelerated stability assessment of dispersions and emulsions |
| 01/06/2005 | WO2005001470A2 Gas chromatography-olfaction analysis device and method |
| 01/06/2005 | WO2005001469A1 Method of acidic polysaccharide analysis and kit for the analysis |
| 01/06/2005 | WO2005001463A1 Voltammetric detection of metabolites in physiological fluids |
| 01/06/2005 | WO2005001462A1 System and method for determining an abused sensor during analyte measurement in a biological fluid |
| 01/06/2005 | WO2005001461A2 Biosensor and method of preparation |
| 01/06/2005 | WO2005001460A2 Gas sensor |
| 01/06/2005 | WO2005001433A1 Use of acacia gum to contain and preserve a biohazard |
| 01/06/2005 | WO2005001429A2 Fluidic circuits, methods and apparatus for use of whole blood samples in colorimetric assays |
| 01/06/2005 | WO2005001427A2 Arrays for chemiluminescent assays, methods of making the arrays and methods of detecting chemiluminescent emission on solid supports |
| 01/06/2005 | WO2005001426A2 Micro scale flow through sorbent plate collection device |
| 01/06/2005 | WO2005001424A2 Systems and methods for molecular recognition |
| 01/06/2005 | WO2005001421A2 Improved piezoimmunosensor |
| 01/06/2005 | WO2005001420A2 Method and apparatus for sensing hydrogen gas |
| 01/06/2005 | WO2005001417A2 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof |
| 01/06/2005 | WO2005001413A2 Method and apparatus for formulating and controlling chemical concentrations in a gas mixture |
| 01/06/2005 | WO2005001411A2 An online flow through microchip for detecting hazardous chemical and biological agents in drinking water |
| 01/06/2005 | WO2005001138A2 Breast cancer survival and recurrence |
| 01/06/2005 | WO2005001136A1 Methods and compositions for modulating erythropoietin expression |
| 01/06/2005 | WO2005001132A2 Gene expression profiles that identify genetically elite ungulate mammals |
| 01/06/2005 | WO2005001130A1 Methods for selecting protein binding moieties |
| 01/06/2005 | WO2005001126A1 Detection kit for gastric cancer and metastatic gastric cancer |
| 01/06/2005 | WO2005001125A1 Method of judging mutation and polymorphism in nucleic acid |
| 01/06/2005 | WO2005001121A1 Substrates for spatially selective micron and nanometer scale deposition and combinatorial modification and fabrication |
| 01/06/2005 | WO2005001120A1 Micro and nano scale fabrication and manufacture by spatially selective deposition |
| 01/06/2005 | WO2005001117A1 Method of selecting wt1 vaccine adaptive patient |
| 01/06/2005 | WO2005001116A1 Utilization of cell forcibly expressing toll-like receptor |
| 01/06/2005 | WO2005001115A2 Monitoring gene silencing and annotating gene function in living cells |
| 01/06/2005 | WO2005001114A2 Screening methods |
| 01/06/2005 | WO2005001108A2 Method and device for characterising a culture solution |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001091A1 Probe set for detecting mutation and polymorphism in nucleic acid, dna array having the same immobilized thereon and method of detecting mutation and polymorphism in nucleic acid using the same |
| 01/06/2005 | WO2005001086A1 IMMOBILIZED mRNA-PUROMYCIN CONJUGATE AND USE THEREOF |
| 01/06/2005 | WO2005001071A1 Cell line and bioassay method using the same |
| 01/06/2005 | WO2005001058A2 Identification of biomarkers for liver toxicity |
| 01/06/2005 | WO2005001052A2 Modulation of apoptosis |
| 01/06/2005 | WO2005001049A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 01/06/2005 | WO2005001026A2 Adks as modifiers of the pten pathway and methods of use |
| 01/06/2005 | WO2005001018A1 Pharmacological measuring device and system and well container used therefor |
| 01/06/2005 | WO2005000875A2 Compositions and methods comprising a ligand of chemerin receptor |
| 01/06/2005 | WO2005000760A2 Non-destructive quality control method for microarray substrate coatings via labeled doping |
| 01/06/2005 | WO2005000308A2 Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| 01/06/2005 | WO2005000196A2 Inhibition of egr-1 expression by rpar-ϝ agonista and related compositions and methods |
| 01/06/2005 | WO2005000099A2 BLOOD FACTOR DOMAINS (BFDs) |
| 01/06/2005 | WO2005000088A2 Expression profile of pancreatic cancer |
| 01/06/2005 | WO2004095221A8 Apparatus and methods for analyzing and characterizing nucleic acid sequences |
| 01/06/2005 | WO2004092213B1 Gene expressed in prostate cancer, methods and use thereof |
| 01/06/2005 | WO2004090550A3 A method for detection of colorectal cancer in human samples |
| 01/06/2005 | WO2004086038A3 A method for screening compounds having the capacity to control tumor cell invasion or metastasis using constitutively active akt |
| 01/06/2005 | WO2004085683A3 Method for early carcinoma detection and a test kit for carrying our said method |
| 01/06/2005 | WO2004083865A3 Materials and methods for modulating cell motility |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004082572A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87) |
| 01/06/2005 | WO2004078906A3 Method for producing a immobilised virus carrier and the use thereof |
| 01/06/2005 | WO2004075813A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 01/06/2005 | WO2004073588A3 Diagnostics and therapeutics for diseases associated with g protein coupled receptor r35 (r35) |
| 01/06/2005 | WO2004073587A3 Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 1 (pthr1) |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004071392A3 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2004070355A3 Wafer inspection using a nonvibrating contact potential difference probe (nonvibrating kelvin probe) |
| 01/06/2005 | WO2004064751A3 Nanoparticle based stabilization of ir fluorescent dyes |
| 01/06/2005 | WO2004058167A3 Breast specific protein expressed in cancer and methods of use thereof |
| 01/06/2005 | WO2004051280A3 Identification of agonistic autoantibodies |
| 01/06/2005 | WO2004046726A3 Methods and kits for assays of rapid screening of diabetes |
| 01/06/2005 | WO2004042342A3 Nuclear pore protein nup88 as a novel target |
| 01/06/2005 | WO2004025294A8 Method for locating ligands bonding to a drug target by means of nmr displacement experiments |
| 01/06/2005 | WO2004023147A3 Maldi-matrix |
| 01/06/2005 | WO2004000003A3 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process |
| 01/06/2005 | WO2003060056A8 Assembly for cell-based assays |
| 01/06/2005 | WO2003056030A9 Methods and systems of nucleic acid sequencing |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003044040A9 Alpha-fetoprotein peptides and uses thereof |
| 01/06/2005 | WO2003041654A3 Anti-estrogen and immune modulator combinations for treating breast cancer |
| 01/06/2005 | WO2003020890A3 Genes encoding baeyer-villiger monooxygenases |
| 01/06/2005 | WO2003000026B1 Integrated automatic blood collection and processing unit |
| 01/06/2005 | US20050005316 Extracellular matrix signaling molecules |
| 01/06/2005 | US20050005314 Animal model comprising constitutively exprressed anaplastic lymphoma kinase (ALK) gene for use in identifying agents which prevent and treat tumor metastasis; gene expression inhibition; RNA interference; immunotherapy |
| 01/06/2005 | US20050005313 Using magnetic resonance imaging to identify tagged tumor marker sequences; prepariing and using antisense agents as therapeutic tools in treatment of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050005309 Method of using animal models to predict adverse drug reactions |
| 01/06/2005 | US20050004771 Apparatus for measuring fruit properties including a function for automatically controlling the intensity of light from a light source |
| 01/06/2005 | US20050004767 Method and system for validating changes in medical practice, procedures and product choice |
| 01/06/2005 | US20050004765 Method for estimating effect of working substance and screening method |
| 01/06/2005 | US20050004538 Urine collection device |